Decatur Capital Management, Inc. Amgen Inc Transaction History

Decatur Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $8.58 Million - $9.64 Million	-51,668 Closed	0 $0
Q1 2018 May 01, 2018	SELL	$169.43 - $198.0 $259,566 - $303,336	-1,532 Reduced 2.88%	51,668 $8.81 Million
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $8.98 Million - $10 Million	53,200	53,200 $9.25 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Decatur Capital Management, Inc. with notifications on news.